Europe · Markets & Finance · Reuters Markets

Liquidia slumps after US court rules for United Therapeutics in patent fight

Published by Reuters Markets · United Kingdom 12 h ago

Liquidia shares plunged nearly 50% on Wednesday after a federal judge ruled that its lung drug infringes key patent held by rival United Therapeutics , dealing a major blow to…

Read the full article on Reuters Markets Sign in to save

MediaNews shows the headline and summary published by the outlet. The full article is on the publisher's website. (www.reuters.com)

Also worth reading

City A.M.

Bring ‘punishing’ high street taxes in line with banks, Healey urged

Financial Times

Trump says South Korea will invest $200bn in US energy projects

This is Money

Bailey's fears AI could trigger next crash should not be sneezed at, says ALEX BRUMMER

FXStreet

The New Zealand Dollar edges lower as US yields outweigh China's beats

Reuters Sustainability

PM Burnham says he would be very concerned if Man City owners sold club

MoneyWeek